What happens when traditional depression treatments stop working? Could a single psychedelic-assisted therapy session create lasting change? What does the latest research reveal about psilocybin's potential in mental healthcare?
In this episode, Joe Sanok speaks with Compass Pathways CEO Kabir Nath about the emerging role of psilocybin-assisted therapy in treating treatment-resistant depression (TRD). They discuss the latest clinical research, how psychedelic therapy is being studied, and its potential to transform mental healthcare.
Podden och tillhörande omslagsbild på den här sidan tillhör
Joe Sanok. Innehållet i podden är skapat av Joe Sanok och inte av,
eller tillsammans med, Poddtoppen.
